The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Vol. 58. Issue 5.
Pages 489-491 (1 May 2003)
Vol. 58. Issue 5.
Pages 489-491 (1 May 2003)
Full text access
Hepatitis C. Hepatitis crónica. Evolución y tratamiento
Visits
15348
L. Hierro Llanillo
Corresponding author
loretohierro@hotmail.com
Servicio de Hepatología. Hospital Infantil La Paz. Madrid. P.o de la Castellana, 261. 28046 Madrid. España.
Servicio de Hepatología. Hospital Infantil La Paz. Madrid. P.o de la Castellana, 261. 28046 Madrid. España.
Servicio de Hepatología. Hospital Infantil La Paz. Madrid. España.
This item has received
Article information
Full text is only available in PDF
Bibliografía
[1.]
P. Jara, M. Resti, L. Hierro, R. Giacchino, C. Barbera, L. Zancan.
Chronic hepatitis C virus infection in childhood: Clinical patterns and evolution in 224 white children.
Clin Infect Dis, 36 (2003), pp. 275-280
[2.]
M. Guido, M. Rugge, P. Jara, L. Hierro, R. Giacchino, J. Larrauri.
Pathology of chronic hepatitis C virus infection in childhood.
Gastroenterology, 115 (1998), pp. 1525-1529
[3.]
M.P. Manns, J.G. McHutchison, S.C. Gordon, V.K. Rustgi, M. Shiffman, R. Reindollar.
Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.A randomized trial.
Lancet, 358 (2001), pp. 958-965
[4.]
K.R. Jacobson, K. Murray, A. Zellos, K.B. Schwarz.
An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.
J Pediatr Gastroenterol Nutr, 34 (2002), pp. 52-58
[5.]
S. Wirth, S. Gehring, T. Lang, P. Gerner.
Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.
Hepatology, 36 (2002), pp. 1280-1284
Copyright © 2003. Asociación Española de Pediatría


